Hindustan TimesLean L·
FDA crackdown on Cipla Pharma's Pune unit, license cancelled over 'unauthorised promotional text'
The FDA seized Reactin Plus stock worth ₹11.19 lakh and ordered the firm to recall the drug from the market.
Read at Hindustan Times →




